<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The authors studied 12 patients with <z:hpo ids='HP_0011010'>chronic</z:hpo> persistent <z:hpo ids='HP_0012115'>hepatitis</z:hpo> and persistent or intermittent mild <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Maximum serum total <z:chebi fb="0" ids="16990">bilirubin</z:chebi> concentration ranged from 2.1 to 3.6 mg/dl </plain></SENT>
<SENT sid="2" pm="."><plain><z:mp ids='MP_0010163'>Hemolysis</z:mp> was not evident </plain></SENT>
<SENT sid="3" pm="."><plain>Hepatic <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronyltransferase activity assayed in each patient ranged from 0.16 to 0.39 U (mean +/- <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e> = 0.27 +/- 0.02) compared to 0.68-1.99 (1.35 +/- 0.08) in 23 <z:mpath ids='MPATH_458'>normals</z:mpath>, 0.78-2.28 (1.41 +/- 0.05) in 53 patients with <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, 0.34-1.74 (0.81 +/- 0.09) in 16 patients with anicteric <z:hpo ids='HP_0011010'>chronic</z:hpo> persistent <z:hpo ids='HP_0012115'>hepatitis</z:hpo>, and 0-0.62 (0.24 +/- 0.03) in 33 patients with <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>The mean <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronyltransferase activity was significantly lower in anicteric <z:hpo ids='HP_0011010'>chronic</z:hpo> persistent <z:hpo ids='HP_0012115'>hepatitis</z:hpo> compared to <z:mpath ids='MPATH_458'>normals</z:mpath>, but higher than in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>The incidence of <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> among first degree relatives was 0:32 in icteric <z:hpo ids='HP_0011010'>chronic</z:hpo> persistent <z:hpo ids='HP_0012115'>hepatitis</z:hpo> compared to 24:85 (28%) in <z:e sem="disease" ids="C0017551" disease_type="Disease or Syndrome" abbrv="">Gilbert's syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>These results show that the likely cause for the <z:hpo ids='HP_0008282'>unconjugated hyperbilirubinemia</z:hpo> associated with <z:hpo ids='HP_0011010'>chronic</z:hpo> persistent <z:hpo ids='HP_0012115'>hepatitis</z:hpo> is an acquired <z:hpo ids='HP_0000716'>depression</z:hpo> of hepatic <z:chebi fb="0" ids="16990">bilirubin</z:chebi> <z:chebi fb="15" ids="17659">UDP</z:chebi>-glucuronyltransferase activity </plain></SENT>
<SENT sid="7" pm="."><plain>The data suggest that the enzyme defect is related to <z:hpo ids='HP_0011010'>chronic</z:hpo> persistent <z:hpo ids='HP_0012115'>hepatitis</z:hpo> </plain></SENT>
</text></document>